Susquehanna International Group, LLP Corcept Therapeutics Inc Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	SELL	$22.21 - $34.48 $12.7 Million - $19.8 Million	-574,000 Reduced 65.74%	299,200 $9.72 Million
Q1 2024 May 07, 2024	BUY	$21.1 - $27.46 $6.48 Million - $8.43 Million	307,000 Added 54.22%	873,200 $22 Million
Q4 2023 Feb 14, 2024	BUY	$24.82 - $32.88 $10.8 Million - $14.3 Million	434,200 Added 328.94%	566,200 $18.4 Million
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $2.23 Million - $3.43 Million	101,500 Added 332.79%	132,000 $3.6 Million
Q2 2023 Aug 11, 2023	SELL	$21.44 - $25.15 $758,976 - $890,310	-35,400 Reduced 53.72%	30,500 $678,000
Q1 2023 May 16, 2023	SELL	$19.2 - $24.47 $117,120 - $149,267	-6,100 Reduced 8.47%	65,900 $1.43 Million
Q4 2022 Feb 14, 2023	SELL	$19.95 - $29.96 $213,465 - $320,572	-10,700 Reduced 12.94%	72,000 $1.46 Million
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $1.07 Million - $1.26 Million	43,400 Added 110.43%	82,700 $2.12 Million
Q2 2022 Aug 15, 2022	SELL	$17.33 - $25.3 $2.63 Million - $3.85 Million	-152,000 Reduced 79.46%	39,300 $935,000
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $2.03 Million - $3.1 Million	122,900 Added 179.68%	191,300 $4.31 Million
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $523,260 - $714,204	-30,600 Reduced 30.91%	68,400 $1.35 Million
Q2 2021 Aug 11, 2021	SELL	$19.97 - $24.43 $3.14 Million - $3.84 Million	-157,200 Reduced 61.36%	99,000 $2.18 Million
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $1.59 Million - $2.08 Million	-67,900 Reduced 20.95%	256,200 $6.1 Million
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $6.68 Million - $10.9 Million	-397,800 Reduced 55.1%	324,100 $8.48 Million
Q3 2020 Nov 16, 2020	BUY	$12.46 - $19.98 $5.82 Million - $9.33 Million	466,800 Added 182.99%	721,900 $12.6 Million
Q2 2020 Aug 14, 2020	SELL	$11.0 - $18.26 $303,600 - $503,976	-27,600 Reduced 9.76%	255,100 $4.29 Million
Q1 2020 May 15, 2020	BUY	$10.11 - $14.04 $1.01 Million - $1.4 Million	99,800 Added 54.57%	282,700 $3.36 Million
Q4 2019 Feb 14, 2020	BUY	$12.06 - $16.96 $531,846 - $747,936	44,100 Added 31.77%	182,900 $2.21 Million
Q3 2019 Nov 14, 2019	SELL	$10.41 - $14.66 $770,340 - $1.08 Million	-74,000 Reduced 34.77%	138,800 $1.96 Million
Q2 2019 Aug 14, 2019	BUY	$9.78 - $12.76 $1.24 Million - $1.62 Million	127,200 Added 148.6%	212,800 $2.37 Million
Q1 2019 May 15, 2019	SELL	$10.03 - $15.71 $1.46 Million - $2.28 Million	-145,300 Reduced 62.93%	85,600 $1.01 Million
Q4 2018 Feb 14, 2019	BUY	$11.29 - $17.19 $308,217 - $469,287	27,300 Added 13.41%	230,900 $3.09 Million
Q3 2018 Nov 14, 2018	BUY	$12.27 - $15.65 $1.23 Million - $1.57 Million	100,400 Added 97.29%	203,600 $2.85 Million
Q2 2018 Aug 14, 2018	SELL	$15.3 - $19.69 $2.37 Million - $3.05 Million	-154,700 Reduced 59.98%	103,200 $1.62 Million
Q1 2018 May 15, 2018	BUY	$14.59 - $25.5 $1.04 Million - $1.83 Million	71,600 Added 38.43%	257,900 $4.24 Million
Q4 2017 Feb 14, 2018	BUY	$15.77 - $20.72 $1.38 Million - $1.81 Million	87,300 Added 88.18%	186,300 $3.37 Million
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $1.22 Million - $1.91 Million	99,000	99,000 $1.91 Million

Others Institutions Holding CORT

# of Institutions

311

Shares Held

88.3M

Call Options Held

1.07M

Put Options Held

973K

Black Rock Inc. New York, NY

16.5M
Shares

$774 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

9.55M
Shares

$447 Million
0.01% of portfolio
Ingalls & Snyder LLC New York, NY

8.24M
Shares

$385 Million
11.51% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

6.91M
Shares

$323 Million
0.4% of portfolio
Parallel Advisors, LLC

3.82M
Shares

$179 Million
3.2% of portfolio

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.01B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account